Janux Therapeutics, Inc.(JANX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

JANX Janux Therapeutics, Inc.

未开盘 08-15 16:00:00 EDT

41.52

+1.35

+3.36%

盘后41.52

+0.000.00%

16:06 EDT

最高42.14	最低39.55	成交量58.59万
今开41.11	昨收40.17	日振幅6.44%
总市值21.66亿	流通市值10.70亿	总股本5,216万
成交额2,415万	换手率2.27%	流通股本2,576万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"JANX","market":"US","secType":"STK","nameCN":"Janux Therapeutics, Inc.","latestPrice":41.52,"timestamp":1723752000000,"preClose":40.17,"halted":0,"volume":585872,"hourTrading":{"tag":"盘后","latestPrice":41.52,"preClose":41.52,"latestTime":"16:06 EDT","volume":10674,"amount":443186.94,"timestamp":1723752396067},"delay":0,"floatShares":25761608,"shares":52162215,"eps":-0.899033,"marketStatus":"未开盘","marketStatusCode":0,"change":1.35,"latestTime":"08-15 16:00:00 EDT","open":41.11,"high":42.14,"low":39.5525,"amount":24145777.0848,"amplitude":0.064414,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.899033,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1723795200000},"adr":0,"listingDate":1623384000000,"adjPreClose":40.17,"preHourTrading":{"tag":"盘前","latestPrice":41.09,"preClose":40.17,"latestTime":"09:29 EDT","volume":230,"amount":9432.94975,"timestamp":1723728599999},"postHourTrading":{"tag":"盘后","latestPrice":41.52,"preClose":41.52,"latestTime":"16:06 EDT","volume":10674,"amount":443186.94,"timestamp":1723752396067},"volumeRatio":0.952621,"impliedVol":0.8521,"impliedVolPercentile":0.3028},"requestUrl":"/m/hq/s/JANX","defaultTab":"news","newsList":[{"id":"2458692137","title":"Janux Therapeutics, Inc.2024财年第二财季实现净利润-5.96百万美元，同比增加65.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458692137","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458692137?lang=zh_cn&edition=full","pubTime":"2024-08-12 00:10","pubTimestamp":1723392638,"startTime":"0","endTime":"0","summary":"8月12日，Janux Therapeutics, Inc.公布财报，公告显示公司2024财年第二财季净利润为-5.96百万美元，同比增加65.96%；其中营业收入为8.90百万美元，同比增加739.62%，每股基本收益为-0.11美元。从资产负债表来看，Janux Therapeutics, Inc.总负债33.74百万美元，其中短期债务1.63百万美元，资产负债比为0.21，流动比率为0.58。机构评级：截至2024年8月12日，当前有8家机构对Janux Therapeutics, Inc.目标价做出预测，其中目标均价为67.25美元，其中最低目标价为42.00美元，最高目标价为100.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081200104195904260&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081200104195904260&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","JANX"],"gpt_icon":0},{"id":"2455861866","title":"Janux Therapeutics, Inc.盘中异动 大幅跳水5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2455861866","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455861866?lang=zh_cn&edition=full","pubTime":"2024-07-30 03:45","pubTimestamp":1722282328,"startTime":"0","endTime":"0","summary":"北京时间2024年07月30日03时45分，Janux Therapeutics, Inc.股票出现波动，股价大幅跳水5.00%。Janux Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.07%。Janux Therapeutics, Inc.公司简介：Janux Therapeutics Inc 是一家临床阶段的生物制药公司，基于专有的肿瘤激活 T Cell Engager 平台技术开发下一代疗法，以更好地治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240730034528af94a6ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240730034528af94a6ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","JANX","BK4539","LENZ"],"gpt_icon":0},{"id":"2454372045","title":"Janux Therapeutics, Inc.盘中异动 急速上涨5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2454372045","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454372045?lang=zh_cn&edition=full","pubTime":"2024-07-27 03:40","pubTimestamp":1722022805,"startTime":"0","endTime":"0","summary":"北京时间2024年07月27日03时40分，Janux Therapeutics, Inc.股票出现异动，股价急速上涨5.12%。Janux Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。Janux Therapeutics, Inc.公司简介：Janux Therapeutics Inc 是一家临床阶段的生物制药公司，基于专有的肿瘤激活 T Cell Engager 平台技术开发下一代疗法，以更好地治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240727034005af945e48&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240727034005af945e48&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","JANX","LENZ","BK4539"],"gpt_icon":0},{"id":"2454382913","title":"成分股MeiraGTx收涨11.62%，AC Immune涨10.76%，诺瓦瓦克斯医药涨8.25%表现第三，和黄医药则收跌3.","url":"https://stock-news.laohu8.com/highlight/detail?id=2454382913","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454382913?lang=zh_cn&edition=full","pubTime":"2024-07-26 04:45","pubTimestamp":1721940358,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"live_wallstreetcn","url":"https://wallstreetcn.com/live/a-stock","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wallstreetcn.com/live/a-stock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_wallstreetcn","symbols":["BK4139","00013","BK4007","NVAX","BK4585","BK4539","BK4588","BK4568","BK4531","BK4135","JANX","HCM","BK1588","BK1191","BK1587","EWTX","AC","BK4547","LENZ"],"gpt_icon":0},{"id":"2451071918","title":"Janux Therapeutics, Inc.盘中异动 早盘大幅拉升5.04%报45.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2451071918","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2451071918?lang=zh_cn&edition=full","pubTime":"2024-07-16 21:50","pubTimestamp":1721137822,"startTime":"0","endTime":"0","summary":"北京时间2024年07月16日21时50分，Janux Therapeutics, Inc.股票出现波动，股价快速上涨5.04%。截至发稿，该股报45.66美元/股，成交量2.8974万股，换手率0.06%，振幅3.36%。Janux Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.54%。Janux Therapeutics, Inc.公司简介：Janux Therapeutics Inc 是一家临床阶段的生物制药公司，基于专有的肿瘤激活 T Cell Engager 平台技术开发下一代疗法，以更好地治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407162150229681d31e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407162150229681d31e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","JANX","BK4539"],"gpt_icon":0},{"id":"2442544552","title":"Janux Therapeutics, Inc.盘中异动 快速拉升5.69%报44.43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2442544552","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2442544552?lang=zh_cn&edition=full","pubTime":"2024-06-12 21:31","pubTimestamp":1718199097,"startTime":"0","endTime":"0","summary":"北京时间2024年06月12日21时31分，Janux Therapeutics, Inc.股票出现波动，股价大幅拉升5.69%。截至发稿，该股报44.43美元/股，成交量4517股，换手率0.01%，振幅0.00%。Janux Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.34%。Janux Therapeutics, Inc.公司简介：Janux Therapeutics Inc 是一家临床阶段的生物制药公司，基于专有的肿瘤激活 T Cell Engager 平台技术开发下一代疗法，以更好地治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061221313896813b09&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061221313896813b09&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","JANX","BK4539"],"gpt_icon":0},{"id":"2441265826","title":"成分股阿玛琳（AMRN）收跌17.91%，Summit Therapeutics Plc.、23Andme Holding Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2441265826","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2441265826?lang=zh_cn&edition=full","pubTime":"2024-06-05 05:25","pubTimestamp":1717536302,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"live_wallstreetcn","url":"https://wallstreetcn.com/live/a-stock","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wallstreetcn.com/live/a-stock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_wallstreetcn","symbols":["BK1191","BK4588","BK1587","BK1161","BK4548","HCM","LENZ","BK4539","00013","ZLAB","BK4531","BK4139","BK4585","AMRN","BK4007","BK1588","JANX","BK4526","BK1574","09688"],"gpt_icon":0},{"id":"2440235195","title":"Janux Therapeutics, Inc.盘中异动 股价大跌5.00%报52.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2440235195","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2440235195?lang=zh_cn&edition=full","pubTime":"2024-06-04 21:42","pubTimestamp":1717508553,"startTime":"0","endTime":"0","summary":"北京时间2024年06月04日21时42分，Janux Therapeutics, Inc.股票出现异动，股价急速跳水5.00%。截至发稿，该股报52.23美元/股，成交量1.9957万股，换手率0.04%，振幅3.62%。Janux Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。Janux Therapeutics, Inc.公司简介：Janux Therapeutics Inc 是一家临床阶段的生物制药公司，基于专有的肿瘤激活 T Cell Engager 平台技术开发下一代疗法，以更好地治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240604214233af8beeb6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240604214233af8beeb6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","LENZ","JANX"],"gpt_icon":0},{"id":"2439918815","title":"Janux Therapeutics, Inc.盘中异动 早盘急速拉升5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2439918815","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2439918815?lang=zh_cn&edition=full","pubTime":"2024-05-31 22:14","pubTimestamp":1717164868,"startTime":"0","endTime":"0","summary":"北京时间2024年05月31日22时14分，Janux Therapeutics, Inc.股票出现异动，股价快速上涨5.24%。Janux Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.16%。Janux Therapeutics, Inc.公司简介：Janux Therapeutics Inc 是一家临床阶段的生物制药公司，基于专有的肿瘤激活 T Cell Engager 平台技术开发下一代疗法，以更好地治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405312214289681121d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405312214289681121d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","JANX","BK4539","BK4139"],"gpt_icon":0},{"id":"2439251623","title":"Janux Therapeutics(JANX.US)获Scotiabank首次覆盖，给予与大盘持平评级, 目标价47.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2439251623","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2439251623?lang=zh_cn&edition=full","pubTime":"2024-05-30 22:36","pubTimestamp":1717079813,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4539","LENZ","JANX","BK4139"],"gpt_icon":0},{"id":"2439616174","title":"Janux Therapeutics Inc：丰业银行以行业表现评级和47美元的目标股价启动保险","url":"https://stock-news.laohu8.com/highlight/detail?id=2439616174","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2439616174?lang=zh_cn&edition=full","pubTime":"2024-05-30 18:11","pubTimestamp":1717063885,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4207","BNS","LENZ","BK4139","JANX","BK4539"],"gpt_icon":0},{"id":"2434408302","title":"成分股SIGA Tech收跌28.30%，Y mAbs Therapeutics跌20.92%，阿玛琳（AMRN）、Editas Medicine、Avadel Pharmaceuticals Plc.","url":"https://stock-news.laohu8.com/highlight/detail?id=2434408302","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2434408302?lang=zh_cn&edition=full","pubTime":"2024-05-09 07:53","pubTimestamp":1715212426,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"live_wallstreetcn","url":"https://wallstreetcn.com/live/us-stock","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wallstreetcn.com/live/us-stock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_wallstreetcn","symbols":["BK4139","LENZ","BK4588","MXCT","BK4007","AMRN","JANX","PCRX","BK4539","BK4121","MYGN","PACB","SIGA","BK4585","BK4583"],"gpt_icon":0},{"id":"2433772111","title":"Janux Therapeutics, Inc.股价重挫12.70% 市值跌3.54亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433772111","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2433772111?lang=zh_cn&edition=full","pubTime":"2024-05-08 21:32","pubTimestamp":1715175157,"startTime":"0","endTime":"0","summary":"北京时间2024年05月08日21时32分，Janux Therapeutics, Inc.股票出现异动，股价急速下跌12.70%。Janux Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.32%。Janux Therapeutics, Inc.公司简介：Janux Therapeutics Inc 是一家临床阶段的生物制药公司，基于专有的肿瘤激活 T Cell Engager 平台技术开发下一代疗法，以更好地治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405082132388ae8dd85&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405082132388ae8dd85&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["JANX","LENZ","BK4139","BK4539"],"gpt_icon":0},{"id":"2432953056","title":"Janux Therapeutics, Inc.盘中异动 快速拉升5.10%报61.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432953056","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2432953056?lang=zh_cn&edition=full","pubTime":"2024-05-03 03:44","pubTimestamp":1714679070,"startTime":"0","endTime":"0","summary":"北京时间2024年05月03日03时44分，Janux Therapeutics, Inc.股票出现异动，股价急速拉升5.10%。Janux Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.72%。Janux Therapeutics, Inc.公司简介：Janux Therapeutics Inc 是一家临床阶段的生物制药公司，基于专有的肿瘤激活 T Cell Engager 平台技术开发下一代疗法，以更好地治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405030344307a57f040&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405030344307a57f040&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","LENZ","BK4139","JANX"],"gpt_icon":0},{"id":"2431755871","title":"成分股医药研发公司Deciphera Pharma收涨72.56%领跑，日本ONO Pharmaceutical同意以每股25.","url":"https://stock-news.laohu8.com/highlight/detail?id=2431755871","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2431755871?lang=zh_cn&edition=full","pubTime":"2024-04-30 07:42","pubTimestamp":1714434152,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"live_wallstreetcn","url":"https://wallstreetcn.com/live/a-stock","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wallstreetcn.com/live/a-stock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_wallstreetcn","symbols":["BK1161","159938","BK4505","LU1923623000.USD","LU1951198990.SGD","JANX","LU1951200564.SGD","VTYX","BK4554","BK4539","BK4588","CABA","RAPT","EXAI","BK1515","BK4576","BK4139","BK1574","09939","BK4007","LENZ","BK4023","CYTK","BK4585","PTC"],"gpt_icon":0},{"id":"2431611268","title":"Janux Therapeutics, Inc.盘中异动 股价大涨5.07%报49.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2431611268","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2431611268?lang=zh_cn&edition=full","pubTime":"2024-04-29 21:58","pubTimestamp":1714399133,"startTime":"0","endTime":"0","summary":"北京时间2024年04月29日21时58分，Janux Therapeutics, Inc.股票出现波动，股价快速上涨5.07%。截至发稿，该股报49.80美元/股，成交量8.0935万股，换手率0.16%，振幅4.58%。Janux Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.82%。Janux Therapeutics, Inc.公司简介：Janux Therapeutics Inc 是一家临床阶段的生物制药公司，基于专有的肿瘤激活 T Cell Engager 平台技术开发下一代疗法，以更好地治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240429215854861ea1a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240429215854861ea1a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4539","JANX"],"gpt_icon":0},{"id":"2427842743","title":"Janux Therapeutics(JANX.US)获JonesTrading首次覆盖，给予买入评级, 目标价70.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2427842743","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2427842743?lang=zh_cn&edition=full","pubTime":"2024-04-16 18:49","pubTimestamp":1713264599,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["JANX","BK4539","LENZ","BK4139"],"gpt_icon":0},{"id":"2427381548","title":"美国研究综述-卡特彼勒、高盛、Netflix","url":"https://stock-news.laohu8.com/highlight/detail?id=2427381548","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2427381548?lang=zh_cn&edition=full","pubTime":"2024-04-16 15:18","pubTimestamp":1713251928,"startTime":"0","endTime":"0","summary":"    路透社4月16日 - 华尔街证券分析师周二调整了对卡特彼勒、高盛和 Netflix 等多家美国上市公司的评级和目标价。要闻              * 卡特彼勒公司  ：摩根大通将目标价从385美元上调至435美元             * 高盛  ：汇丰银行将目标价从460美元上调至470美元             * Netflix Inc   ：麦格理将目标价从595美元上调至685美元以下是路透社周二报道的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MPW","SCHW","STLD","BK4504","LU1718418525.SGD","IE00BKVL7J92.USD","LU0719512351.SGD","IE00BD6J9T35.USD","MTW","LU2098885051.SGD","LU0011850046.USD","SG9999003800.SGD","SG9999004303.SGD","LU1201861249.SGD","LU0175139822.USD","LU0708994859.HKD","LU1720051017.SGD","BK4534","CCK","GS","SG9999011175.SGD","IE0004445015.USD","CAT","LU1861217088.USD","LU2355687059.USD","NFLX","LU1064131342.USD","BERY","LU0170899867.USD","GNTY","LU1046421795.USD","LU1983260115.SGD","MTB","NUE","LU1303367103.USD","TRV","HHH","OSK","BOOT","JANX","LU1267930573.SGD","LU1861220207.SGD","LU0980610538.SGD","LU1720051108.HKD","BK4516","IE00BJJMRY28.SGD","PGR","LU0310800379.SGD","LU0029874061.USD"],"gpt_icon":0},{"id":"2426218072","title":"成分股Alpine Immune Sciences收涨36.90%，Enliven Therapeutics涨20.18%，Vera Therapeutics、Savara、Janux Therapeutics、AnaptysBio、Alx Oncology Holdings涨17.","url":"https://stock-news.laohu8.com/highlight/detail?id=2426218072","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2426218072?lang=zh_cn&edition=full","pubTime":"2024-04-12 05:02","pubTimestamp":1712869355,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"live_wallstreetcn","url":"https://wallstreetcn.com/live/a-stock","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wallstreetcn.com/live/a-stock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_wallstreetcn","symbols":["VERA","BK4007","LENZ","BK4585","BK4139","JANX","APGE","TBPH","BK4539","BK4588"],"gpt_icon":0},{"id":"2426477425","title":"成分股Tourmaline Bio收跌13.02%，Nurix跌10.24%，Adaptive Biotechnologies跌8.","url":"https://stock-news.laohu8.com/highlight/detail?id=2426477425","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2426477425?lang=zh_cn&edition=full","pubTime":"2024-04-11 05:33","pubTimestamp":1712784810,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"live_wallstreetcn","url":"https://wallstreetcn.com/live/a-stock","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wallstreetcn.com/live/a-stock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_wallstreetcn","symbols":["JANX","BK4585","BK4539","TRML","BK4588","LENZ","VERV","BK4139","VERA"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.januxrx.com","stockEarnings":[{"period":"1week","weight":0.1378},{"period":"1month","weight":-0.1048},{"period":"3month","weight":-0.1185},{"period":"6month","weight":3.403},{"period":"1year","weight":2.7138},{"period":"ytd","weight":2.8695}],"compareEarnings":[{"period":"1week","weight":0.0423},{"period":"1month","weight":-0.0209},{"period":"3month","weight":0.0446},{"period":"6month","weight":0.1072},{"period":"1year","weight":0.258},{"period":"ytd","weight":0.1636}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Janux Therapeutics, Inc.于2017年6月27日在特拉华州注册成立。该公司是一家创新的生物制药公司，开发基于该公司专有的肿瘤激活T细胞接合器（TRACTr）平台技术的下一代疗法，以更好地治疗癌症患者。该公司最初的重点是开发一类新的T细胞接合器（TCE），该公司的主要候选产品是针对临床验证的药物靶点设计的。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":0.085364},{"month":2,"riseRate":0.666667,"avgChangeRate":1.511745},{"month":3,"riseRate":0,"avgChangeRate":-0.221441},{"month":4,"riseRate":0.666667,"avgChangeRate":0.155417},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.057273},{"month":6,"riseRate":0.666667,"avgChangeRate":-0.03282},{"month":7,"riseRate":0.75,"avgChangeRate":0.116412},{"month":8,"riseRate":0.5,"avgChangeRate":-0.067239},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.06598},{"month":10,"riseRate":0.666667,"avgChangeRate":0.032653},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.051859},{"month":12,"riseRate":0.666667,"avgChangeRate":0.101437}],"exchange":"NASDAQ","name":"Janux Therapeutics, Inc.","nameEN":"Janux Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Janux Therapeutics, Inc.(JANX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Janux Therapeutics, Inc.(JANX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Janux Therapeutics, Inc.,JANX,Janux Therapeutics, Inc.股票,Janux Therapeutics, Inc.股票老虎,Janux Therapeutics, Inc.股票老虎国际,Janux Therapeutics, Inc.行情,Janux Therapeutics, Inc.股票行情,Janux Therapeutics, Inc.股价,Janux Therapeutics, Inc.股市,Janux Therapeutics, Inc.股票价格,Janux Therapeutics, Inc.股票交易,Janux Therapeutics, Inc.股票购买,Janux Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Janux Therapeutics, Inc.(JANX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Janux Therapeutics, Inc.(JANX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}